bn:03402513n
Noun Named Entity
SYL
No term available
EN
BEACOPP is a chemotherapy regimen for treatment of Hodgkin lymphoma developed by the German Hodgkin Study Group used for patients in Stages > II or early with unfavorable risk factors. Wikipedia
Relations
Sources